 Ductal carcinoma situ microinvasion curable entity surgery need adjuvant therapy negative axillary node NAN patients Roswell Park Cancer Institute Buffalo NY ductal carcinoma situ microinvasion DCISM patients disease mammography microcalcifications radiological density cm Thirty-three patients underwent modified radical mastectomy wide excision axillary dissection Residual disease excisional biopsy mastectomy specimens pure ductal carcinoma situ DCISM invasive incidents residual disease multicentric third specimens findings high likelihood residual cancer excisional biopsy patients patients free disease mean follow-up months range findings DCISM curable disease mastectomy need adjuvant therapy status prognostic factors tumor size histologic differentiation age steroid receptor status